3M Introduces New Adhesive For Wearable Medical Devices

US-based manufacturing company 3M has introduced a new adhesive for its product line of advanced adhesives. The company announced that it has developed a new adhesive called3M Extended Wear Medical Transfer Adhesive, 4075, expanding its range of wearable medical devices. This unique adhesive is designed to laminate various substrates and also features an extended wear pressure sensitive transfer adhesive. The adhesive permits design engineers to use different backings. It also provides excellent initial skin adhesion, allowing up to 14-day wear time, depending on the type of backing material.

It is a challenging task for design engineers to create an adhesive that can efficiently stick to the skin. It is imperative that the adhesives give optimum results. Adhesives are an integral part of the device that holds it together while also staying on the wearer’s skin; both of which are necessary for the device’s success. With the new adhesive, 3M aims to extend the wear time of products that provides customers a wide variety of backings along with design flexibility. It is part of the company’s strategy to avail design engineers more patient-friendly adhesive options without compromising on comfort, strength, and durability. The new transfer adhesive, 4075 has been tested to examine its in vitro cytotoxicity and the possibility of causing irritation and skin sensitization. It has fulfilled the requirements and has proven to be suitable for use on intact skin. It is also compatible with the process of ethylene oxide sterilization. It belongs to the extensive adhesive product portfolio that 3M offers to its customers in medical device manufacturing, supply, and design industries.

Recently, 3M’s Drug Delivery Systems Division shifted its research and development laboratory to Charnwood Campus in Loughborough. This move will help the company bring its teams under one roof with nearly 120 employees from the research and development wing. The campus is the first and only officially designated Life Sciences Opportunity Zone (LSOZ) in the United Kingdom and was built to bring together science and technology-based organizations.



Eric has been working for world chronicle since the company’s birth. Having exceptional writing skills, he is well read in several disciplines including literature, history, politics, and science.

Related Articles